| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -5.07M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GALT returned -8.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -9.4% |
| 1 year | -8.0% |
| 5 years | -4.1% |
| 10 years | +119.2% |
| All-time high | $33.00 (Sep 2003) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GALT would be worth today ›No. Galectin Therapeutics Inc. has not paid a dividend in the past 12 months.
Galectin Therapeutics Inc. stock trades on NASDAQ under the ticker symbol GALT.
Galectin Therapeutics Inc. is part of the Healthcare sector.
Galectin Therapeutics Inc. has a market cap of 380.20M USD, based on the latest quote.
